Mobile Menu

Week in Brief: Week Ending 22nd August

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from the last seven days.

Immunologists have found that two proteins, TCF1 and LEF1, are essential for the anti-inflammatory function and self-renewal of a specific type of immune cell called B-1a cells in mice. These findings also provide clues about the potential role of these cells in humans.

Researchers have identified how lymphoma can rewire the human genome. A chromosomal translocation has been seen to impact gene regulation across a 50 million base pair stretch of the genome, affecting around 50 genes and promoting cancer progression.

Interactions between inherited and novel mutations could influence lifetime risk of developing blood cancer, according to a new study. The authors suggest that this could be the case across a variety of other cancers, and that these findings could be used to assist in early detection.

It has been announced that an NHS trust in London will trial the use of AI to write the documents needed to discharge patients, meaning wards can be freed up and patients can return home sooner.

An analysis of healthcare data from over 4 million children has shown that antibiotic exposure in infancy is not related to the risk of future autoimmune diseases. This is in contrast to previous studies, which suggested that a mother’s antibiotic use during pregnancy or breastfeeding may be linked to the incidence of conditions like Type I diabetes or Crohn’s disease.

Researchers have developed a new AI tool to simulate cancer genomes for research. This method could be used to analyse mutational signatures and other cancer drivers, allowing for the development of precision therapies without breaching compromising patient confidentiality.

A large-scale multi-omics study has identified a number of genetic and molecular links to non-AIDS comorbidities in people living with HIV. The results of the study have been used to form a ‘molecular map’ that could guide further research.

A large international study has used whole-genome sequencing to map the decades-long development of multiple myeloma, showing that key DNA-damaging events often begin in early adulthood and shape disease progression. The findings could help to group patients into disease subtypes, offering new precision medicine opportunities.

Researchers developed a multi-target transformer model that can simultaneously predict numerous genetic alterations directly from routine histological colon cancer tissue slides. Validated across nearly 2,000 samples from multiple cohorts, the model outperformed traditional single-target approaches.

Finally, following a Mediterranean diet may decrease the risk of developing dementia. A new study has shown that individuals with a high genetic predisposition for Alzheimer’s benefit most from this dietary intervention.

Check out last week’s Week in Brief here.


More on these topics

Genomics / Multi-omics